Skip To Main Content
Eline Menu on Muck Rack

Eline Menu

As seen in: Color Research & Application, Nature, Wiley Online Library, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eline

Contact Eline, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Novel SLAMF1-derived peptide induces apoptosis in multiple myeloma cells by targeting IRF4 transcription factor for degradation

|
By Ingvild Bergdal Mestvedt, Eline Menu, Kristine Misund, Tobias S. Slørdahl
| BioRxiv
Abstract Multiple myeloma (MM) is the second most common hematological cancer. It remains incurable, highlighting the urgent need for novel therapeutic targets and treatment strategies. In this study, we investigated a panel of peptides derived from a functional motif of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) with single amino acid substitutions and found that several of them exhibited potent anti-cancer activity by inducing MM cell death.
Open in Who Shared Issue with article?

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia - Blood Cancer Journal

|
By Elke De Bruyne, Eline Menu, Ann MacLean Massie, Ken Maes
| Nature Verified
Abstract Acute Myeloid Leukemia (AML) is a heterogeneous disease with limited treatment options and a high demand for novel targeted therapies. Since myeloid-related protein S100A9 is abundantly expressed in AML, we aimed to unravel the therapeutic impact and underlying mechanisms of targeting both intracellular and extracellular S100A9 protein in AML cell lines and primary patient samples.
Open in Who Shared Issue with article?

Tumor-associated macrophage-mediated survival of myeloma cells through STAT3 activation

|
By Ken Maes, Nathan De Beule, Kim De Veirman, Elke De Bruyne, Eline Menu, Karine Breckpot, Hendrik De Raeve, Rian Van Rampelbergh, Rik Schots, Els Van Valckenborgh, Karin Vanderkerken
| Color Research & Application Verified
Overcoming drug resistance is one of the greatest challenges in the treatment of multiple myeloma (MM). The interaction of myeloma cells with the bone marrow (BM) micro-environment is a major contributing factor to drug resistance. Tumor-associated macrophages or TAMs with different polarization states are an important component of this micro-environment.
Open in Who Shared Issue with article?
See all 3 articles